Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for RADL3

Update shared on 03 Nov 2025

Fair value Increased 1.52%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-9.2%
7D
17.6%

Narrative Update on Raia Drogasil

Analysts have slightly increased their price target for Raia Drogasil to R$22.25 from R$21.91. This change reflects modest improvements in projected revenue growth and profit margin, which contributed to a higher assessed fair value.

What's in the News

  • Raia Drogasil recently hosted its Analyst/Investor Day, providing updates and insights for investors (Key Developments).

Valuation Changes

  • The Fair Value Price Target has risen slightly, moving from R$21.91 to R$22.25.
  • The Discount Rate has edged down marginally, from 18.37% to 18.36%.
  • Revenue Growth projections have increased moderately, from 14.49% to 14.51%.
  • The Net Profit Margin has improved slightly, moving from 3.37% to 3.40%.
  • The Future P/E Ratio has increased a little, from 29.93x to 30.10x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.